Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 38

Oncology

Pharma News and Updates for Sanofi ViiV Argenx Novartis UCB Kyowa

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Sanofi’s Rare Disease Drug Xenpozyme’ Approval; FDA Approves Novartis’ Pluvicto; AstraZeneca’s Imfinzi Trial Result; FDA’s Green Signal to Argenx’ Vyvgart; ViiV Healthcare and J&J’s HIV Treatment Cabenuva; UCB’s FINTEPLA Approval; Cullinan’s Update for CLN-081; MEI Pharma & Kyowa’s Zandelisib Approval

Sanofi’s Rare Disease Drug Xenpozyme Wins World’s First Approval in Japan Sanofi’s Xenpozyme, also known as olipudase alfa, the world's first therapy for the rare disease Niemann-Pick type A/B and B, has been approved for the treatment of children and adults with non-CNS manifestations of Acid Sphingomyelinase Deficiency (ASMD) by Japan's drug regulator. Sanofi hopes to receive approvals for the drug in the United States and Europe before the end of the year. Xenpozyme is a recombinant human Acid Sphingomyelinase (ASM) enzyme designed to replace deficient or defective ASM. It is only approved in Japan for the treatment of ASMD types A/B and B, and it has not been s...

Explore More...

CAR T cell therapy

66 Year Ohio Woman Becomes Cancer Free, Thanks to CAR T Cell Therapy

artificial intelligence

Now, Artificial Intelligence to Accurately Identify Cancer Cells

cancer

Gold Nanoparticles May Soon Treat Prostate Cancer

tumor cell

Cancer Cells Trick Body’s Immunity to Survive against Treatment

Johnson & Johnson

Notizia

cancer cells

Scientists Now Target Attacking Evolution Process of Cancer Cells

Chemotherapy as a treatment for Cancer?

Cambrex acquires Avista; Sobi pays $50M; LEO Pharma signs deal; Boston Scientific remunerates

Actinic Keratosis – A Warning Sign for Potential Skin Cancer

Synthorx needs IPO; Deerfield puts up $80M; SVB remunerates; Celgene’s deal

glaxosmithkline

Notizia

Virus, the Cancer Therapy of the Future

TNBC Triple Negative Breast Cancer

Triple Negative Breast Cancer

Sanofi

Gordon and Betty Moore Foundation gives $85M; Omeicos raises; Sanofi signs deal; Lilly grabs

FDA

FDA approves Zulresso; Pfizer receives approval; Novartis relinquishes Rituxan

Lung cancer infographic

Lung Cancer Infographic

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly